Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 23 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2025
AS PHARMA from Charleroi, company number BE0792238986, closed financial year 2025 with a result of € 9,997 after tax. For that financial year AS PHARMA recorded a gross margin of € 92,388 and equity of € 144,219. Compared with financial year 2024, the result moved from € 80,929 to € 9,997. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.
€ 144,219
▲ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,997
▼ 88% vs 2024
Profit after tax over the fiscal year.
€ 11,406
▼ 21% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 94,219.
People and assets in 2025
€ 36,314
▲ 54% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 957,971
▼ 7% vs 2024
€ 78,599 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 4,131
▲ € 3,951 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 8,668
▼ 71% vs 2024
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 43,514 | € 173,622 | € 92,388 | ▼ 47% |
| Profit after taxes | € 3,293 | € 80,929 | € 9,997 | ▼ 88% |
| Equity | € 53,293 | € 134,222 | € 144,219 | ▲ 7% |
| Total debts | € 1,355,918 | € 1,476,455 | € 1,470,922 | |
| Cash | € 6,510 | € 14,490 | € 11,406 | ▼ 21% |
| Retained profit | € 3,293 | € 84,222 | € 94,219 | ▲ 12% |
| Bank debt | € 1,100,000 | € 1,033,466 | € 957,971 | ▼ 7% |
| Balance sheet total | € 1,409,211 | € 1,610,677 | € 1,615,142 |
By gross margin, AS PHARMA ranks 2nd of 4 companies with main activity “Detailhandel in farmaceutische producten” in Charleroi that publish figures (fiscal year 2025).
Key figures of AS PHARMA, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about AS PHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to AS PHARMA?
What happened at AS PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,997 (▼ 88% vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Charleroi. KBO
- Alessio Stefanelli became a director. NBB
In short
From € 3,293 profit in 2023 to € 9,997 profit in 2025.
Paid € 32,917 in corporate taxes since 2023.
Best year ever: 2024, with € 80,929 profit.
Management
Behind AS PHARMA is Alessio Stefanelli. It owns 100% of PHARMACIE CATRIN itself.
Directors
According to the 2025 annual accounts
Alessio Stefanelli
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Rue Jean Jaurès 272
6020 Charleroi
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Charleroi
Same main activity (Detailhandel in farmaceutische producten), 3 active companies in Charleroi, largest first.
€ 161,772 gross margin · 2025
€ 90,424 gross margin · 2025
€ 62,595 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Alessio Jean David STEFANELLI(oprichter) 100%
Details
- Company number
- 0792.238.986
- VAT number
- BE 0792.238.986
- Registered office
- Rue Jean Jaurès 272, 6020 Charleroi
- Names & denominations
- AS PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 October 2022
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Administratieve en ondersteunende activiteiten ten behoeve van kantoren
Overige zakelijke dienstverlening, neg
Fotokopiëren, documentvoorbereiding en andere gespecialiseerde ondersteunende activiteiten ten behoeve van kantoren
Diverse administratieve activiteiten ten behoeve van kantoren